Extended Data Fig. 6: In vivo behavior of circulating tumor-reactive T cells - Arm C.
From: Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial
Trends and profile of circulating T cells specific for both targeted (left side) and non-targeted (right side) TAAs in each individual patient treated in arm C. Results are reported as SFC/2×105 at each specified time point. Arm C patients #s 13, 27 and 40 (who were not resected and were thus deemed non-evaluable for further analysis as per study protocol) and 20 (who only received a single infusion due to post-surgical complications and was deemed non-evaluable) are not included in this analysis.
